The replacement of glutamic acid with lysine at position 434 (PNPLA3 148M, rs2294918) impairs ubiquitylation and proteasomal degradation, resulting in lipid droplet accumulation and NAFLD development [15]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.